Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With SurvivalShaan Dudani, Daniel Y.C. Heng|JAMA Network Open|2021Cited by 295
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Sarah Abou Alaiwi et al.|Nature Communications|2021Cited by 167
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell CarcinomaRana R. McKay, Toni K. Choueiri, Dominick Bossé et al.|Cancer Immunology Research|2018Cited by 136
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Daniel Y.C. Heng et al.|Cancers|2019Cited by 31
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J. Kwiatkowski, Sabina Signoretti, Toni K. Choueiri et al.|Unknown|2023Cited by 0